A study published in July 2025 issue of Journal of Neurology explored how genetic variability in the FCGR2/3 locus, which ...

Acute flaccid paralysis in children is a medical emergency that can progress to respiratory failure within hours or days, ...

Doctors and genetic researchers at The University of Manchester have discovered that changes in a gene leads to severe nerve damage in children following a mild bout of infection.

Annexon offers speculative upside with Tanruprubart, targeting Guillain-Barré Syndrome's unmet needs. Click here to read my ...

Guillain-Barré Syndrome Risk Linked to COVID-19 and Certain Vaccines A global study sheds light on the relationship between Guillain-Barré syndrome after certain COVID-19 vaccines.

New research shows COVID-19 raises the risk of Guillain-Barré syndrome more than vaccines. mRNA vaccines pose no increased risk, global data reveals.

Over the past 20 years, the most notable advance in understanding Guillain–Barré syndrome (GBS) has been the identification of an axonal variant. This advance arose chiefly through studies undertaken ...

Valley man spreading awareness about Guillain-Barré Syndrome Guillain-Barré Syndrome is a condition that attacks a person's nerves. It can lead to muscle weakness and sometimes paralysis.

Guillain Barré syndrome (GBS) varies both in terms of clinical phenotype and underlying pathology. Serial assessments allow greater understanding of the pathophysiology. The evolution of ...

CIDP is often considered the chronic form of Guillain-Barré Syndrome and, as such, can be more problematic in that it lasts longer, causes more damage and is more difficult to recover from.

Scientists have linked Zika firmly to Guillain-Barré syndrome, known for triggering temporary paralysis.

Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome. That's welcome news.